Efficacy and Safety of Infliximab Versus Adalimumab in the Therapy of Fistulizing Crohn Disease: A Systematic Review and Indirect Comparison

doi 10.37766/inplasy2020.4.0089
Full Text
Abstract

Available in full text

Date
Authors
Publisher

INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy